VectorWorks
VectorWorks Raises $200M Growth to Transform Biotech
Quick Facts
VectorWorks Raises $200M Growth in Latest Funding Round
VectorWorks has successfully closed a $200M Growth funding round, marking a significant milestone in the company's growth trajectory. The round was led by Accel, with participation from Thrive Capital.
Company Overview
Founded in 2024 and headquartered in San Francisco, CA, VectorWorks has established itself in the Biotech space. Leading AI-powered analytics platform transforming data into actionable business insights
With a current valuation of $15B, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $200M Growth
- Valuation: $15B
- Lead Investor: Accel
Future Outlook
As VectorWorks moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
NeuralTech Raises $100M Growth to Transform Biotech
NeuralTech has secured $100M Growth in funding to accelerate growth and innovation. Leading AI-powered analytics platform transforming data into actionable business insights...